Position in BIOA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$403,791
New position
Shares Held
23,087
first reported quarter
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Quantinno Capital Management LP holds $190,557,921 across 33 Drug Manufacturers - Specialty & Generic names. BIOA ranks #26 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
1,680,427 | $40,212,618 | |
| 2 | ZTS |
Zoetis Inc.
|
330,839 | $39,108,478 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,289,326 | $23,878,317 | |
| 4 | VTRS |
Viatris Inc
|
1,161,696 | $15,694,512 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
21,135 | $12,532,632 | |
| 6 | HLN |
Haleon plc
|
1,221,499 | $12,227,204 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
69,499 | $9,155,798 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
637,094 | $8,823,751 |
All Filings in BIOA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $403,791 | 23,087 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||